Application of continuous veno-venous hemofiltration in patients with acute respiratory distress syndrome

National Medical Journal of China

Volumn 88, Issue 32, 2008, Pages 2274-2277

  Jin, Zhao Chen ^a   Yu, Zhi Xin ^b   Ji, Mu Sen ^b   Zhou, Hong ^a  

^a JIANGSU UNIVERSITY   (China)

^b NONE

Author keywords

Continuous renal replacement therapy; Interleukin 6; Respiratory distress syndrome, adult; Systemic inflammatory response syndrome

Indexed keywords

INTERLEUKIN 6;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG INJURY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; APACHE; HEMOFILTRATION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 54949122119     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pork WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med, 2001, 164:1896-1903.
2. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol, 2005, 33:319-327.
3. Chinese source.
4. Takala A, Nupponen I, Kylanpaa-Back ML, et al. Markers of inflammation in sepsis. Ann Med, 2002, 34:614-623.
5. Pettilä V, Hynninen M, Takkunen O, et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med, 2002, 28:1220-1225.
6. Bellomo R, Ronco C. Continuous haemofiltration in the intensive care unit. Crit Care, 2000, 4:339-345.
7. Peng Y, Yuan Z, Li H. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis. Burns, 2005, 31:623-628.
8. Ullrich R, Roeder G, Lorber C, et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology, 2001, 95:428-436.
9. Su X, Bai C, Hong Q, et al. Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury. Intensive Care Med, 2003, 29: 2034-2042.
10. DiCarlo JV, Alexander SR, Agarwal R, et al. Continuous venovenous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol, 2003, 25: 801-805.
11. Chinese source.
12. Chinese source.
13. Meduri GU. Diagnosis of ventilator-associated pneumonia. Infect Dis Clin North Am, 1993, 7:295-329.
14. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today, 1997, 18:428-432.
15. Koperna T, Semmler D, Marian F. Risk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment? Arch Surg, 2001, 136: 55-59.
16. Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol, 2005, 175:3463-3468.
17. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med, 2000, 28:3581-3587.
18. Meduri GU. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit Care, 2002